Journal of Gastroenterology
Springer Science+Business Media · JP · ISSN 09441174
SJR Q1
What the numbers say
More papers are appearing but each one is getting fewer citations on average.
Field-weighted citation impact moved from 3.57 to 2.56. If you rely on high citedness per paper, look elsewhere. Output grew sharply while citation impact fell. Expect a busier publication roster that may dilute average attention per article. Inflammatory Bowel Disease rose from 10.5% to 18.4% of what the journal runs. Consider submitting if your work is on inflammatory bowel disease. The University of Tokyo leads all institutions with 93 papers. Readers should note a strong institutional concentration among contributors.
Citation metrics
SJR quartile
Q1
SJR score
1.86
Citations / doc (2y)
5.45
h-index
159
Based on the Scopus and OpenAlex citation graphs. We do not provide Clarivate’s JCR Impact Factor.
Output and citation impact
Whether citation performance keeps up as output grows.
PapersField-weighted impact
2018
109
3.57
2019
122
3.31
2020
93
2.53
2021
87
4.37
2022
106
3.35
2023
121
2.99
2024
137
2.47
2025
133
2.56
Topic shift
Share in the last 24 months (2024-09 – 2026-08) versus the previous 24 (2022-09 – 2024-08).
Rising
- Inflammatory Bowel Disease10.5%→18.4%+7.9%pPrevNow
- Hepatocellular Carcinoma Treatment and Prognosis2.5%→7.2%+4.8%pPrevNow
- Gallbladder and Bile Duct Disorders0.0%→2.4%+2.4%pPrevNow
- Gut microbiota and health0.0%→2.4%+2.4%pPrevNow
- Extracellular vesicles in disease0.0%→2.4%+2.4%pPrevNow
Falling
- Colorectal Cancer Screening and Detection4.3%→0.0%−4.3%pPrevNow
- Liver Disease and Transplantation9.9%→5.8%−4.1%pPrevNow
- Genetic factors in colorectal cancer3.7%→0.0%−3.7%pPrevNow
- Pancreatitis Pathology and Treatment3.1%→0.0%−3.1%pPrevNow
- Gastric Cancer Management and Outcomes8.0%→5.3%−2.7%pPrevNow
Terms appearing more often
Wording in recent paper titles that stands out against the journal's own baseline.
recompensationmasldatezolizumab
Author countries
Last 24 months (2024-09 – 2026-08) against the previous 24 (2022-09 – 2024-08).
- JP64.0%→58.9%−5.1%pPrevNow
- CN16.4%→21.8%+5.4%pPrevNow
- US9.2%→9.8%+0.6%pPrevNow
- DE0.0%→2.2%+2.2%pPrevNow
- KR2.0%→2.2%+0.2%pPrevNow
- TW0.0%→2.0%+2.0%pPrevNow
Top 5 institutions
Top 5 institutions publishing in this journal, 2018 – 2026.
Recently published
20The 20 most recent papers — not the full list.
1
Article2026
Hypoxia-mediated chromatin accessibility reprogramming of CA9 induces treatment resistance in colorectal mucinous adenocarcinomaAn Huang, Haopeng Hong, Zhuang Sun, Zhaoya Gao, Yong Yang, J K Chen, Yonghui Sun, Z Li*, M Li*, J Gu*
Pulmonary and Respiratory MedicineMedicine
2
Article2026
Stage-associated remodeling of CD169 macrophage states is linked to immune regulation in colitis-associated colorectal cancerYuan Xia, Yu Liu, Ai Peng, Yating Su, Rongyin Sun, Masota Tanaka, Chunhong Qiu*
OAImmunologyImmunology and Microbiology
3
Article2026
Mucosal-associated invariant T cells promote PDAC progression via TL1A–CSF-1 axisLong‐Yun Ye, Q Fei, TT Li, Huiyi Ou, Shuai Wang, Yiting Zhang, Yi Zhou, Xianjun Yu*, Kaizhou Jin*, Weiding Wu*
OAImmunologyImmunology and Microbiology
4
Article2026
Prevalence and incidence of chronic kidney disease in patients with primary biliary cholangitisJosé Manuel Sousa, Sergio Rodríguez‐Tajes, Manuel Hernández-Guerra, Marta Casado, Marina Berenguer, Ylenia Pérez-Castaño, Rosa Morillas, Montserrat Garcı́a-Retortillo, Luisa García-Buey, Má Simón, Elena Góméz, Francisco Jorquera, Conrado Fernández-Rodríguez, Helena Hernández-Évole, Javier Ampuero*
HepatologyMedicine
5
Article2026
Paired tumor–normal metabolomic profiling reveals alterations in choline phospholipid precursor metabolism in biliary tract cancerHironobu Suto*, Kensuke Kumamoto, Mina Nagao, Yumi Furuichi, Takuro Fuke, Hiroyuki Matsukawa, Yasuhisa Ando, Minoru Oshima, Kiyoyuki Kobayashi, H Kobara, Tomoyoshi Soga, Keiichi Okano
Molecular BiologyBiochemistry, Genetics and Molecular Biology
6
Article2026
Methods to build and maintain effective clinician–patient relationships for adults with disorders of gut–brain interaction (DGBI): a systematic reviewHiroshi Mihara*, Juntaro Matsuzaki*, Takuya Okugawa, Tadayuki Oshima, Akihiro Asakawa, Takeshi Kamiya, Takaomi Kessoku, Hidekazu Suzuki, Ken Nakamura, Mariko Hojo, Hideki Mori, Takatsugu Yamamoto, Fumio Tanaka, Seiji Futagami, Ken Haruma, Takashi Joh, Motoyasu Kusano, Koji Yakabi
GastroenterologyMedicine
7
Article2026
Comment on: Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel diseaseRong Peng, Lingzhen Lin, Chengqian Ye*
GeneticsBiochemistry, Genetics and Molecular Biology
8
Article2026
Regulatory mechanism of the RNF168–SCCA1–MYH9 signaling axis in the response of ulcerative colitisXuanqi Zhang, Junyan Zhu, Fang Wei, Lingyi Bu, Yingying Xing*
GeneticsBiochemistry, Genetics and Molecular Biology
9
Article2026
The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based studyBregje Mol, Kim van Munster, R Weersma, Akin Inderson, Kirsten Boonstra, Joost Drenth, Suzanne van Meer, Elsemieke de Vries, Marcel Spanier, A A Vrij, Tessa Verlaan, Femke van Duijn, Willemijn Ponsioen, Marcel Dijkgraaf, Cyriel Y. Ponsioen*, on behalf of the EpiPSC2 study group
OAHepatologyMedicine
10
Article2026
HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activationFutang Li, Ming Yang, Xinghao Sun, Liwen Chen, Dijie Zheng, Zikai Wei, Yanyu Gong, Zhiwei He*, Chao Yu*
OACancer ResearchBiochemistry, Genetics and Molecular Biology
11
Article2026
Emerging omics diagnosis of perihilar cholangiocarcinomaEnis Özmert, Shelby Kohatsu Yee, Sumera I. Ilyas, Rory Lane Smoot, Gregory J. Gores*
OASurgeryMedicine
12
Article2026
Conditional accuracy after lesion preselection: comment on Minakata et al.Ying Liu, J Chen*
Pulmonary and Respiratory MedicineMedicine
13
Article2026
Inhibiting METTL3 synergizes with Notch blockade to treat ESCC by targeting cancer stemness via m6A-JAG2Jingjing Duan, Yingying Jin, Yue Chen, Yinghui Shi, Haotian Wang, Ming Bai, Feixue Wang, Yuchong Yang, Shaohua Ge, Min Zhu, Yi Ba*, Zhongyi Fan*, Ting Deng*
OAMolecular BiologyBiochemistry, Genetics and Molecular Biology
14
Article2026
SEVs-carried ENPP1 regulates DCs’ activation and inhibits the formation of tertiary lymphoid structures in gastric cancerWenbo Liu, Bingyu Wang, Xinyu Yuan, Zhiran Yang, Yingying Wang, Zhiyuan Wang, Yong Li, Fang Li, Limian Er, Bibo Tan*
Molecular BiologyBiochemistry, Genetics and Molecular Biology
15
Article2026
Reply to “Prognostic value of functional assessment in sarcopenia among pancreatic cancer patients”Tomoya Emori, M Itonaga, Reiko Ashida, T. Ishihara, Akiya Nakahata, Yuki Kawaji, Takashi Tamura, Y Yamashita, Kazuhiro Fukatsu, M Kitano*
OAPhysiologyMedicine
16
Article2026
Reelin level in serum-derived extracellular vesicles predicts regression of M2BPGi-defined liver fibrosis following hepatitis C virus eradication by direct-acting antiviral agentsT Suzuki, Kentaro Matsuura*, Yutaka Hashimoto, Masako Okina, Mayumi Hojo, Hayato Kawamura, Kei Fujiwara, Katsuya Nagaoka, Takehisa Watanabe, Hiromi Kataoka, Yasuhito Tanaka
Molecular BiologyBiochemistry, Genetics and Molecular Biology
17
Article2026
Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational studyYo Ishihara, Eikichi Ihara, Mitsuru Esaki, Kota Takahashi, Naoki Tomita, Thanh Huy Dang, Makoto Ohira, Mayu Horiuchi, Ayaka Uchida, Yukiko Toriumi, Toshihiro Nishizawa, Hidenori Ohkubo, Kento Imajo, Shunsuke Oyamada, Tomoyuki Iwasaki, Takeo Kurihashi, Atsushi Yamauchi, Michiko Nakazato, Atsushi Nakajima, Takaomi Kessoku*
OAGastroenterologyMedicine
18
Article2026
RNF207 promotes colorectal cancer growth by regulating the Hippo–YAP pathway via enhanced MST1 ubiquitination and degradationMeng Wang, Xing Wen, Mei Yang, Jie Zhang, Jianhui Gu, Tianqi Lu*
OACell BiologyBiochemistry, Genetics and Molecular Biology
19
Article2026
Comment on “Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease”: treatment comparison or treatment sequencing?Xichen Fan, G L Zhang*
GeneticsBiochemistry, Genetics and Molecular Biology
20
Article2026
A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective studyMasaki Miyazawa*, Hajime Takatori, Masaki Nishitani, Takuya Komura, Kiichiro Kaji, Masaaki Yano, Kazuya Kitamura, Ryotaro Nakai, Hiroki Matsukawa, Naoki Takemura, Masahiro Yanagi, Kazuki Nagai, Hidenori Kido, Noboru Takata, Tomoyuki Hayashi, Akihiro Seki, Kouki Nio, Shinya Yamada, Noriho Iida, Tetsuro Shimakami, Taro Yamashita
OARheumatologyMedicine
Most cited
20Top 20 most cited, 2018 – 2026.
1
ArticleCitations 6932018
Evidence-based clinical practice guidelines for inflammatory bowel diseaseKatsuyoshi Matsuoka, Taku Kobayashi, Fumiaki Ueno*, Toshiyuki Matsui, Fumihito Hirai, Nagamu Inoue, Jun Kato, Kenji Kobayashi, Kiyonori Kobayashi, Kazutaka Koganei, Reiko Kunisaki, Satoshi Motoya, Masakazu Nagahori, Hiroshi Nakase, Fumio Omata, Masayuki Saruta, Toshiaki Watanabe, Toshiaki Tanaka, Takanori Kanai∥, Yoshinori Noguchi, Ken-ichi Takahashi, Kenji Watanabe, Toshifumi Hibi∥, Yasuo Suzuki, Mamoru Watanabe, Kentaro Sugano, Tooru Shimosegawa
OAGeneticsBiochemistry, Genetics and Molecular Biology
2
ReviewCitations 4852021
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020Hiroshi Nakase*, Motoi Uchino, Shinichiro Shinzaki, Minoru Matsuura, Katsuyoshi Matsuoka, Taku Kobayashi, Masayuki Saruta, Fumihito Hirai, Keisuke Hata, Sakiko Hiraoka, Motohiro Esaki, Ken Sugimoto, Toshimitsu Fuji, Kenji Watanabe, Shirô Nakamura, Nagamu Inoue, Toshiyuki Itoh, Makoto Naganuma, Tadakazu Hisamatsu, Mamoru Watanabe, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa, Kazuhiko Koike
OAGeneticsBiochemistry, Genetics and Molecular Biology
3
ReviewCitations 4172021
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020Hitoshi Yoshiji*, Sumiko Nagoshi, Takemi Akahane, Yoshinari Asaoka, Yoshiyuki Ueno, Koji Ogawa, Takumi Kawaguchi, Masayuki Kurosaki, Isao Sakaida, Masahito Shimizu, Makiko Taniai, Shuji Terai, Hiroki Nishikawa, Yoichi Hiasa, Hisashi Hidaka, Hiroto Miwa, Kazuaki Chayama, Nobuyuki Enomoto, Tooru Shimosegawa, Tetsuo Takehara, Kazuhiko Koike
OAEpidemiologyMedicine
4
ArticleCitations 3242018
Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjectsTomohisa Takagi*, Yuji Naito, Ryo Inoüe, Saori Kashiwagi, Kazuhiko Uchiyama, Katsura Mizushima, Saeko Tsuchiya, Osamu Dohi, Naohisa Yoshida, Kazuhiro Kamada, Takeshi Ishikawa, Osamu Handa, Hideyuki Konishi, Kayo Okuda, Yoshimasa Tsujimoto, Hiromu Ohnogi, Yoshito Itoh
Molecular BiologyBiochemistry, Genetics and Molecular Biology
5
ReviewCitations 3042018
Impact of endoscopic ultrasonography on diagnosis of pancreatic cancerMasayuki Kitano*, Takeichi Yoshida, Masahiro Itonaga, Takashi Tamura, Keiichi Hatamaru, Yasunobu Yamashita
OAOncologyMedicine
6
ReviewCitations 2932019
Sarcopenia in cirrhosis: from pathogenesis to interventionsMaryam Ebadi, Rahima A. Bhanji, Vera C. Mazurak, Aldo J. Montaño‐Loza
OAPhysiologyMedicine
7
ReviewCitations 2672021
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020Katsutoshi Tokushige*, Kenichi Ikejima, Masafumi Ono, Yuichiro Eguchi, Yoshihiro Kamada, Yoshito Itoh, Norio Akuta, Masato Yoneda, Motoh Iwasa, Masashi Yoneda, Motoyuki Otsuka, Nobuharu Tamaki, Tomomi Kogiso, Hiroto Miwa, Kazuaki Chayama, Nobuyuki Enomoto, Tooru Shimosegawa, Tetsuo Takehara, Kazuhiko Koike
OAEpidemiologyMedicine
8
ReviewCitations 2532021
Evidence-based clinical practice guidelines for peptic ulcer disease 2020Tomoari Kamada*, Kiichi Satoh, Toshiyuki Itoh, Masanori Ito, Junichi Iwamoto, Tadayoshi Okimoto, Takeshi Kanno, Mitsushige Sugimoto, Toshimi Chiba, Sachiyo Nomura, Mitsuyo Mieda, Hideyuki Hiraishi, Junji Yoshino, Atsushi Takagi, Sumio Watanabe, Kazuhiko Koike
OASurgeryMedicine
9
ArticleCitations 2482018
Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and miceYin Zhu, Cong He, Xueyang Li, Yan Cai, Jinxiang Hu, Yuanhang Liao, Jianhua Zhao, Liang Xia, Wenhua He, Linmeng Liu, Chun Luo, Xu Shu, Qiang Cai, Youxiang Chen, Nonghua Lü*
SurgeryMedicine
10
ArticleCitations 2382018
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 updateRyosuke Tateishi*, Koji Uchino, Naoto Fujiwara, Tetsuo Takehara, Takeshi Okanoue, Masataka Seike, Hitoshi Yoshiji, Hiroshi Yatsuhashi, Masahito Shimizu, Takuji Torimura, Mitsuhiko Moriyama, Isao Sakaida, Hiroyuki Okada, Tetsuhiro Chiba, Makoto Chuma, Kazuhiko Nakao, Hajime Isomoto, Yutaka Sasaki, Shuichi Kaneko, Tsutomu Masaki, Kazuaki Chayama, Kazuhiko Koike
OAEpidemiologyMedicine
11
ReviewCitations 2352022
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021Katsuhiko Iwakiri*, Yasuhiro Fujiwara, Noriaki Manabe, Eikichi Ihara, Shiko Kuribayashi, Junichi Akiyama, Takashi Kondo, Hiroshi Yamashita, Norihisa Ishimura, Yuichi Kitasako, Katsunori Iijima, Tomoyuki Koike, Nobuo Omura, Tsutomu Nomura, Osamu Kawamura, Shuichi Ohara, Soji Ozawa, Yoshikazu Kinoshita, Satoshi Mochida, Nobuyuki Enomoto, Tooru Shimosegawa, Kazuhiko Koike
OAGastroenterologyMedicine
12
ArticleCitations 2272019
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subsetTatsuya Yamashita*, Masatoshi Kudo, Kenji Ikeda, Namiki Izumi, Ryosuke Tateishi, Masafumi Ikeda, Hiroshi Aikata, Yasunori Kawaguchi, Yoshiyuki Wada, Kazushi Numata, Yoshitaka Inaba, Ryoko Kuromatsu, Masahiro Kobayashi, Takuji Okusaka, Toshiyuki Tamai, Chifumi Kitamura, Kenichi Saito, Katsuya Haruna, Kiwamu Okita, Hiromitsu Kumada
OAHepatologyMedicine
13
ReviewCitations 2012019
Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectivesHaiming Hu, Aizhen Lin, Mingwang Kong, Xiaowei Yao, Mingzhu Yin, Hui Xia, Jun Ma, Hongtao Liu
OAEpidemiologyMedicine
14
ArticleCitations 1882021
Evidence-based clinical practice guidelines for irritable bowel syndrome 2020Shin Fukudo*, Toshikatsu Okumura, Masahiko Inamori, Yusuke Okuyama, Motoyori Kanazawa, Takeshi Kamiya, Ken Sato, Akiko Shiotani, Yuji Naito, Yoshiko Fujikawa, Ryota Hokari, T Masaoka, Kazuma Fujimoto, Hiroshi Kaneko, Akira Torii, Kei Matsueda, Hiroto Miwa, Nobuyuki Enomoto, Tooru Shimosegawa, Kazuhiko Koike
OAGastroenterologyMedicine
15
ReviewCitations 1812019
Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancersYuji Eso, Takahiro Shimizu, Haruhiko Takeda, Atsushi Takai, Hiroyuki Marusawa
OAPathology and Forensic MedicineMedicine
16
ArticleCitations 1792019
Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016Collaborators, Atsushi Masamune*, Kazuhiro Kikuta, Shin Hamada, Ichiro Tsuji, Yoshifumi Takeyama, Tooru Shimosegawa, Kazuichi Okazaki
OARheumatologyMedicine
17
ReviewCitations 1732018
Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosisKen Shirabe*, Yuki Bekki, Dolgormaa Gantumur, Kenichiro Araki, Norihiro Ishii, Atsushi Kuno, Hisashi Narimatsu, Masashi Mizokami
EpidemiologyMedicine
18
ReviewCitations 1712018
New treatment options for inflammatory bowel diseasesBram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche
OAGeneticsBiochemistry, Genetics and Molecular Biology
19
ReviewCitations 1682018
Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel diseaseStefan Schreiber*, Axel Dignaß, Laurent Peyrin‐Biroulet, Greg Hather, Dirk Demuth, Mahmoud Mosli, Rebecca Curtis, Javaria Mona Khalid, Edward V. Loftus
OAGeneticsBiochemistry, Genetics and Molecular Biology
20
ReviewCitations 1612019
The mesenchymal stem cell secretome as an acellular regenerative therapy for liver diseaseJulia Driscoll*, Tushar Patel
OAGeneticsMedicine
Similar journals
Check your draft against this journal
Start free with Nubint AI — citation checks and a peer-review simulation.
Data as of 2026-09-05